Sleep Problem in Post COVID-19 Patient, Its Impact on Quality of Life and Current Management: An Evidence-based of Case Report

Authors

  • Hamzah Shatri 1. Division of Psychosomatic and Palliative, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo National Hospital, Jakarta, Indonesia. 2. Clinical Epidemiology Unit, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia – Cipto Mangunkusumo National Hospital, Jakarta, Indonesia.
  • Rizka Zainudin Department of Internal Medicine, Faculty Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Yanuar Ardani Division of Psychosomatic and Palliative, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo National Hospital, Jakarta, Indonesia
  • Edward Faisal Division of Psychosomatic and Palliative, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo National Hospital, Jakarta, Indonesia
  • Rudi Putranto Division of Psychosomatic and Palliative, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo National Hospital, Jakarta, Indonesia

Keywords:

sleep problem, post COVID-19, quality of life, cognitive behavioral therapy

Abstract

Background: COVID-19 is a global health problem that affects both physical and psychological aspect of patients. Sleep problems were experienced by many patients during the acute phase of after COVID-19 recovery. It affects patient’s quality of life and required comprehensive management. This evidence-based case report aims to study the effect of sleep disturbance on quality of life and what is the appropriate management in post COVID-19 patients. Methods: searching were conducted in Pubmed, Cohcrane, EBSCO according to clinical questions. Study was selected based on inclusion and exclusion criteria, then it was critically appraised. Results: high score on the insomnia severity index and the Pittsburgh sleep quality index were found to be associated with quality of life. Cognitive Behavioural Therapy is currently the best evidence-based treatment in patient during and after COVID-19. Conclusion: sleep disturbance is a problem that many post COVID-19 patient face and CBT can improve their quality of life.

Author Biography

Hamzah Shatri, 1. Division of Psychosomatic and Palliative, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo National Hospital, Jakarta, Indonesia. 2. Clinical Epidemiology Unit, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia – Cipto Mangunkusumo National Hospital, Jakarta, Indonesia.

Psychosomatic and Palliative Medicine, Departement of Internal Medicine, Faculty Medicine Universitas Indonesia-Cipto Mangunkusumo Hospital

References

Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed [Internet]. 2020 [cited 2022 Mar 8];91(1):157–60. Available from: https://pubmed.ncbi.nlm.nih.gov/32191675/

WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data [Internet]. 2022 [cited 2022 Mar 8]. Available from: https://covid19.who.int/

Dubey S, Biswas P, Ghosh R, et al. Psychosocial impact of COVID-19. Diabetes Metab Syndr [Internet]. 2020 Sep 1 [cited 2022 Mar 8];14(5):779–88. Available from: https://pubmed.ncbi.nlm.nih.gov/32526627/

El Sayed S, Gomaa S, Shokry D, Kabil A, Eissa A. Sleep in post-COVID-19 recovery period and its impact on different domains of quality of life. Egypt J Neurol psychiatry Neurosurg [Internet]. 2021 Dec 1 [cited 2022 Mar 8];57(1). Available from: https://pubmed.ncbi.nlm.nih.gov/34924750/

Choi EPH, Hui BPH, Wan EYF. Depression and anxiety in Hong Kong during COVID-19. Int J Environ Res Public Health [Internet]. 2020 May 5 [cited 2022 Mar 8];17(10). Available from: https://pubmed.ncbi.nlm.nih.gov/32466251/

Saputra BD, Levita J, Mustarichie R. Efficacy, Safety, and Drug. Drug interactions for insomnia therapy in COVID-19 patients. J Multidiscip Healthc [Internet]. 2022 Jan 21 [cited 2022 Mar 8];15:137–52. Available from: https://www.dovepress.com/efficacy-safety-and-drugdrug-interactions-for-insomnia-therapy-in-covi-peer-reviewed-fulltext-article-JMDH

Becker PM. Overview of sleep management during COVID-19. Sleep Med [Internet]. 2021 [cited 2022 Mar 8]; Available from: /pmc/articles/PMC8106485/

Maramis MM. Pandemi COVID-19 dan ansietas. In: Sutrisno, Kalalo RT, Andrianto, editors. COVID-19 dan problematika kesehatan mental. Surabaya: Ikatan Dokter Indonesia Wilayah Jawa Timur; 2021. p. 73–104.

Wichniak A, Kania A, Siemiński M, Cubała WJ. Melatonin as a potential adjuvant treatment for COVID-19 beyond sleep disorders. Int J Mol Sci [Internet]. 2021 Aug 2 [cited 2022 Mar 8];22(16). Available from: https://pubmed.ncbi.nlm.nih.gov/34445329/

Khawam E, Khouli H, Pozuelo L. Treating acute anxiety in patients with COVID-19. Cleve Clin J Med [Internet]. 2020 May 14 [cited 2022 Mar 8];87(5):1–4. Available from: https://www.ccjm.org/content/early/2020/05/12/ccjm.87a.ccc016.

Downloads

Published

2023-07-28

How to Cite

Shatri, H., Zainudin, R., Ardani, Y., Faisal, E., & Putranto, R. (2023). Sleep Problem in Post COVID-19 Patient, Its Impact on Quality of Life and Current Management: An Evidence-based of Case Report. Acta Medica Indonesiana, 55(2), 226. Retrieved from https://actamedindones.org/index.php/ijim/article/view/2098

Issue

Vol. 55 No. 2 (2023): Acta Medica Indonesiana

Section

SPECIAL ARTICLE

License

Copyright

The authors who publish in this journal agree to the following requirements:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a  Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.